• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Insights & Articles
    • The Clinical Landscape: Strategic Insights into Retinal Care
      • The Modern Clinical Retina Landscape: A Strategic Overview
      • Surgical Approaches to Retinal Detachment: A Comparative Analysis
      • Gene Therapy in Retina: A Commercial and Clinical Appraisal
      • Evolving Treatment Paradigms for Diabetic Macular Edema
      • Analysis of the Anti-VEGF Market: From Revolution to Refinement
      • A Patient’s Guide to Understanding Age-Related Macular Degeneration (AMD)
    • The Business of Retina: Mastering Operations and Financial Health
      • Anatomy of a Retina Practice: A Strategic Guide to Financial Health and Operations
      • The Impact of Private Equity: Reshaping the Business of Retina
      • The Complete 2025 Guide to Ophthalmic J-Codes & Reimbursement
      • The Buy-and-Bill Model: A High-Risk, High-Reward Strategy
      • Staffing for Success: Key Roles in a High-Volume Retina Practice
      • Key Technology Investments for an Efficient Retina Clinic
      • Decoding CMS Reimbursement: A Guide to J-Codes and Revenue Cycle Management
    • The Innovation Pipeline: Shaping the Future of Retinal Care
      • Beyond the Needle: The Future of Drug Delivery in Retina
      • Heads-Up vs. Traditional: A Comparison of Surgical Visualization Platforms
      • How AI is Changing the Game in Retinal Disease Screening
      • The Rise of At-Home Monitoring for AMD
    • The Professional Ecosystem: Building a Career in Retina
      • A Day in the Life of a Retina Specialist: A Day of Preserving Sight
      • Industry vs. Academia: Choosing Your Career Path in Retina
      • The Role of Key Opinion Leaders (KOLs) in Retina
      • Maximizing Your ASRS Experience: A Fellow’s Guide
      • Navigating the Retina World: A Guide to Key Societies, Conferences, and Career Paths
  • Services
    • Search Engine Optimization (SEO) & Reputation Management
    • Content Marketing & Optometrist Network Development
    • Specialized Recruitment & Staffing Support
    • Professional Branding & Key Opinion Leader (KOL) Development
    • On-Demand Patient Education & Marketing Materials
    • Market Intelligence & M&A Consulting
  • Contact Us
    • Events
    • Subscribe
    • Submissions
Retina Consultant

Retina Consultant

Visionary News & Insightful Strategy

Retina Roundup Advertisement

More than one in three Americans cannot afford quality health care when they need it

April 17, 2025 by Retina News Feed Leave a Comment

Click here to view the original post by Healio Ophthalmology.

In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication. 

By clicking the link above, you will be leaving our site to view an article from its original source.


Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.

Please enable JavaScript in your browser to complete this form.
Loading


April 17, 2025

3 min read

Key takeaways:

  • A record number of Americans are unable to access affordable care — a trend “that must be turned back,” a researcher told Healio.
  • Cost insecurity was particularly significant among Black and Hispanic adults.

An estimated record-high 91 million Americans are unable to pay for quality health care if they needed it today, according to a new West Health and Gallup survey.

The inability to pay was especially prevalent among Black and Hispanic adults. Tim Lash, MBA, president of West Health Policy Center, told Healio that the findings “are the consequence of a high-priced health care system.”

Data derived from press release.

“People are skipping or avoiding necessary care in high numbers because they can’t afford it even when many have some form of health insurance. This financial toxicity that travels with health care in this country is, in and of itself, a public health issue,” Lash added. “These are negative trends that must be turned back.”

Using the West Health-Gallup Healthcare Affordability Index, Lash categorized survey recipients as being:

  • cost secure, meaning they faced no recent difficulty affording or accessing care or paying for prescription medicine;
  • cost insecure, meaning they were recently unable to either access care or afford care or prescription medicine; or
  • cost desperate, meaning they were recently unable to access care and afford care and prescription medicine.

A total of 6,296 people aged 18 years or older responded to the survey.

Number of ‘cost desperate’ adults hits new high

The survey showed that just over half (51%) of Americans were classified as cost secure — the lowest percentage since 2021 — while 11% were classified as cost desperate, a new high.

The greatest reductions among those who were cost secure since 2021 were seen in Hispanic adults, falling 17 percentage points to 34%, and Black adults, who fell 13 percentage points to 41%.

Overall, 35% of adults reported being unable to pay for quality, affordable health care — four percentage points higher than 2023 and a new high since 2021 — while 52% and 46% of Hispanic and Black adults reported being unable to afford such care, respectively.

Upward trends in the cost desperate category since 2021 were also substantial for several subgroups. Specifically:

  • Hispanic adults rose by eight percentage points to 18%;
  • Black adults rose by five percentage points to 14%;
  • households earning under $24,000 annually rose by 11 percentage points to 25%; and
  • households earning between $24,000 to $48,000 annually rose by six percentage points to 19%.

In contrast, white adults and households earning between $120,000 to $180,000 annually reported no changes in their access to care.

HCPs should consider financial health

According to Lash, the findings mean that “already over-burdened” health care providers “not only need to focus on the physical and mental health of their patients, but they also need to consider their financial health when prescribing medications or other treatments and scheduling future appointments.”

“The ability to afford treatment must be part of the conversation,” he told Healio. “The best medicines are of no use to people who cannot afford them.”

Lash also highlighted several other solutions needed to address these growing gaps in affordability and improve health outcomes, such as “policy reform, including moving from fee-for-service to value-based payment models, limits on out-of-pocket expenses and health insurance premiums and the expansion of Medicare negotiation.”

Ultimately, “the rise is yet another reflection of the financial strain and real-life anxiety facing Americans trying to stay healthy,” he concluded.

For more information:

Tim Lash, MBA, wishes to be contacted through Tiffany Yu at tyu@westhealth.org.

References:


Sources/Disclosures

Collapse

Disclosures:
Healio could not determine Lash’s relevant financial disclosures at the time of publication.

Read more about

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

More to See

Bariatric Surgery May Outperform GLP-1 RAs in Longer-Term Weight Loss Benefits

December 12, 2025 By AAO News Feed

VIDEO: Ixo-vec gene therapy shows safe results throughout 4-year study period

December 12, 2025 By Healio Ophthalmology

Amniotic membrane superior to bandage contact after CXL

December 12, 2025 By Healio Ophthalmology

Chronic Kidney Disease as a Risk Factor for Age-related Macular Degeneration: Prospective Cohort and Mendelian Randomization Analyses

December 11, 2025 By Ophthalmology Science

Automated feature segmentation of ultra-widefield optical coherence tomography images

December 11, 2025 By Ophthalmology Science

Geographic Atrophy Structure-Function Relationships Based on Loss of OCT Outer Retinal Bands and Fundus Autofluorescence

December 11, 2025 By Ophthalmology Science

Senate rejects legislation to extend ACA subsidies

December 11, 2025 By Healio Ophthalmology

Global ophthalmology: Learning through teaching

December 11, 2025 By Healio Ophthalmology

GLP-1s may reduce risk for cataracts, dry AMD

December 11, 2025 By Healio Ophthalmology

AMA policy combats ‘deepfake doctors’

December 11, 2025 By Healio Ophthalmology

Footer

A RETINA-SPECIFIC ORGANIZATION

It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.

We’ve got our eyes on working with the best retina groups and vendors in the industry.

See the best;  get in touch.

Recent News Posts

  • Surgeon volunteer opportunities available in US
  • Bariatric Surgery May Outperform GLP-1 RAs in Longer-Term Weight Loss Benefits
  • VIDEO: Ixo-vec gene therapy shows safe results throughout 4-year study period
  • Amniotic membrane superior to bandage contact after CXL
  • Chronic Kidney Disease as a Risk Factor for Age-related Macular Degeneration: Prospective Cohort and Mendelian Randomization Analyses

Search

Retina Consultant
Copyright © 2025